Skip to main content

Table 4 Microbiology

From: Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial

 

Azithromycin

 

Placebo

 
 

Baseline

12 weeks

baseline

12 weeks

Microbiology, n (%)

(n = 40)

(n = 30)

(n = 41)

(n = 31)

Streptococcus pneumoniae

5 (11.9)

0 (0)

3 (7.1)

2 (4.8)

Haemophilus influenzae

11 (27.5)

4 (13.3)*

7 (17.1)

10 (32.3)

Moraxella catarrhalis

5 (12.5)

0 (0)

5 (12.2)

3 (9.7)

Pseudomonas aeruginosa

0 (0)

1 (3.3)

2 (4.9)

3 (9.7)

Staphylococcus aureus

1 (2.5)

0 (0)

1 (2.4)*

0 (0)

  1. *one patient with azithromycin resistant bacteria.